ACCESSWIRE
11 Aug 2022, 01:37 GMT+10
NEW YORK, NY / ACCESSWIRE / August 10, 2022 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Yext, Inc. (NYSE:YEXT)
Class Period: March 4, 2021 - March 8, 2022
Lead Plaintiff Deadline: August 16, 2022
The complaint alleges that during the class period Yext, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Yext's revenue and earnings were significantly deteriorating because of, among other things, poor sales execution and performance, as well as COVID-19 related disruptions; (ii) accordingly, Yext was unlikely to meet consensus estimates for its full year fiscal 2022 financial results and fiscal 2023 outlook; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Learn about your recoverable losses in YEXT: https://www.kleinstocklaw.com/pslra-1/yext-lawsuit?id=30742&from=1
Outset Medical, Inc. (NASDAQ:OM)
This lawsuit is on behalf of all persons or entities who purchased Outset Medical common stock between September 15, 2020, and June 13, 2022.
Lead Plaintiff Deadline: September 6, 2022
The complaint alleges Outset Medical, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's flagship product, Tablo Hemodialysis System ('Tablo'), would require an additional 510(k) application to be filed with The United States Food and Drug Administration ('FDA'), as defendants had 'continuously made improvements and updates to Tablo over time since its original clearance' (2) as a result, the Company could not conduct a human factors study on a cleared device in accordance with FDA protocols; (3) the Company's inability to conduct the human factors study subjected the Company to the likelihood of the FDA imposing a 'shipment hold' and marketing suspension, leaving the Company unable to sell Tablo for home use; and (4) as a result, defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and /or lacked a reasonable basis at all relevant times.
Learn about your recoverable losses in OM: https://www.kleinstocklaw.com/pslra-1/loss-submission-form-outset-medical-class-action?id=30742&from=1
Weber Inc. (NYSE:WEBR)
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Weber Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's August 2021 initial public offering.
Lead Plaintiff Deadline: September 27, 2022
Throughout the class period, Weber Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Weber was reasonably likely to implement price increases; (2) as a result, consumer demand for Weber's products was reasonably likely to decrease; (3) due to the resulting inventory buildup, Weber was reasonably likely to run promotions to 'enhance retail sell through' (4) the foregoing would adversely impact Weber's financial results; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Learn about your recoverable losses in WEBR: https://www.kleinstocklaw.com/pslra-1/weber-inc-loss-submission-form?id=30742&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
SOURCE: The Klein Law Firm
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationWASHINGTON D.C.: In response to a safety warning issued by the US National Highway Traffic Safety Administration, Vietnamese electric vehicle ...
NEW YORK CITY, New York: Electric truck manufacturer Nikola Corp said that Nasdaq has delivered a delisting notice for not ...
MINNEAPOLIS, Minnesota: Reuters reported that after facing a backlash from customers, Target is pulling some products from its Pride Collection ...
LONDON, England: The BBC has reported that Jaguar Land Rover owner Tata Motors is planning to build a multi-billion pound ...
MENLO Park, California: As part of the last stage of a three-series round of staff layoffs, part of a plan ...
WASHINGTON D.C.: On its website, the US Federal Trade Commission (FTC) has said it is probing Abbott Laboratories and other ...
CHICAGO, Illinois: Boosted by an ongoing shortage of previously owned houses on the market and a considerable drop in prices ...
Two veteran pitchers very familiar with the opponent are scheduled to go head-to-head Monday when the Pittsburgh Pirates visit the ...
After spinning their wheels during a 3-4 road trip through Ohio, the St. Louis Cardinals will try to regain traction ...
Averaging just 2.9 runs per game in May, the Cleveland Guardians will attempt to kickstart their offense when they open ...
Isaac Paredes homered and drove in four runs, and Wander Franco chipped in with two hits and two RBIs to ...
Goals off corner kicks by Fafa Picault and Teal Bunbury rallied host Nashville SC to a 3-1 victory against the ...